Haoyu Zhao Selected Research

Neoplasms (Cancer)

12/2022	Long-term Dependency Outcomes in Older Adults Following Hepato-Pancreato-Biliary Surgery for Cancer: A Population-based Analysis.
10/2021	Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
1/2021	All-Cause and Cancer-Specific Death of Older Adults Following Surgery for Cancer.
11/2020	Patient-Centered Time-at-Home Outcomes in Older Adults After Surgical Cancer Treatment.
8/2020	Patient-reported symptoms following diagnosis in esophagus cancer patients treated with palliative intent.
1/2020	Operationalizing Outpatient Palliative Care Referral Criteria in Lung Cancer Patients: A Population-Based Cohort Study Using Health Administrative Data.
10/2019	Patterns of Symptoms Burden in Neuroendocrine Tumors: A Population-Based Analysis of Prospective Patient-Reported Outcomes.
1/2017	A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haoyu Zhao Research Topics

Disease

8	Neoplasms (Cancer) 12/2022 - 01/2017
2	Major Depressive Disorder (Major Depressive Disorders) 12/2023 - 01/2023
2	Frailty 01/2021 - 11/2020
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2024
1	Klatskin Tumor 01/2024
1	Atrophy 01/2024
1	Hepatic Insufficiency 01/2024
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Congenital Abnormalities (Deformity) 12/2022
1	Clubfoot (Talipes Equinovarus) 12/2022
1	Cognitive Dysfunction 01/2022
1	COVID-19 11/2021
1	Nausea 10/2021
1	Knee Osteoarthritis 07/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021
1	Thyroid Diseases (Thyroid Disease) 01/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2021
1	Oropharyngeal Neoplasms 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Adenocarcinoma 11/2019

Drug/Important Bio-Agent (IBA)

1	AllergensIBA 01/2024
1	ParaffinIBA 01/2024
1	BilirubinIBA 01/2024
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2023
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Iodide Peroxidase (Deiodinase)IBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2017

Therapy/Procedure

4	Therapeutics 12/2022 - 10/2019
3	Palliative Care (Palliative Therapy) 08/2020 - 01/2020
2	Hepatectomy 01/2024 - 12/2022
2	Drug Therapy (Chemotherapy) 12/2023 - 01/2017
2	Osteotomy 12/2022 - 07/2021
1	Minimally Invasive Surgical Procedures 01/2023
1	Aftercare (After-Treatment) 12/2022
1	Time-to-Treatment 01/2022
1	Radiotherapy 10/2021
1	Erythrocyte Transfusion 01/2021
1	Perioperative Care 01/2021
1	Operative Surgical Procedures 11/2020
1	Pancreaticoduodenectomy 11/2019